Surging Number of Amputations Propelling Demand for Medical Bionics

 With the surging incidence of amputations because of injuries and road accidents, the demand for medical bionics is rising sharply. As per the Association for Safe International Road Travel (ASIRT), around 2.35 million people are disabled or injured in the U.S. every year and road accidents cost nearly $230.6 billion (or an average of $820 per person) in the country. Additionally, as per the Organization for Economic Co-operation and Development (OECD), road accidents surged in the U.S., that is from 1.57 million in 2010 to 1.75 million in 2015, which consequently pushed up the requirement for medical bionics. 

Access Report Summary - Medical Bionics Market Growth

Besides the aforementioned factor, the growing incidence of road accidents is also driving the demand for medical bionics across the world. As per the World Health Organization (WHO), nearly 1.3 million deaths are recorded every year because of road accidents. A traumatic amputation can result in partial or full amputation. In some cases, it may be possible to re-attach the detached body part. In this process, the remaining part of the limb that has been detached is operated upon and a prosthetic limb is fixed. 

Depending on fixation type, medical bionics are divided into implantable and non-implantable bionics. Between these, the demand for implantable bionics was found to be higher in 2017. This was because of the fact that a large number of people opted for organ transplants and the high incidence of chronic diseases across the world. Heart, orthopedic, neural/brain, ear, and vision/eye are the most widely used types of medical bionics. Out of these, the demand for orthopedic medical bionics is predicted to rise at the fastest pace in the coming years.

Hence, it can be said without any doubt that the demand for medical bionics will soar in the coming years, mainly because of the increasing incidence of injuries and amputations because of road accidents, mushrooming population of geriatric people, and rising prevalence of chronic diseases across the world. 

Read More

Clinical Decision Support Systems Receiving Increasing Government Funding

Wherever there is life, there will be disease! Therefore, since the beginning of the human civilization, the focus on health and wellbeing has been strong, regardless of how little understanding of the concept early humans had. In the modern world, healthcare services are dispensed at places ranging from the single-doctor neighborhood clinic to multi-specialty hospitals with hundreds of beds. However, with more diseases being discovered and the footfall of patients steadily rising, even such advanced healthcare facilities are reeling under high pressure to treat as many as possible, as well as possible.

Access Report Summary - Clinical Decision Support System Market Global Industry Analysis and Demand Forecast Report

P&S Intelligence credits this rising patient footfall and the pressure that the global healthcare fraternity is under presently, especially with the raging COVID-19 pandemic, to claim significant growth in the clinical decision support system market from $410.5 million in 2015 at a 22.4% CAGR during 2016–2022. CDSS involves the usage of health information technology (HIT) to offer healthcare professionals support in their day-to-day clinical operations. The idea is to computerize, or, at least, digitize, patient records, diagnoses, treatment recommendations, medication schedules, and other aspects, so that doctors are free to deal with patients personally.

Therefore, CDSS has numerous applications in medical settings, including clinical guidelines, drug–drug interactions, clinical reminders, drug allergy alerts, and drug dosing support. Presently, these systems are majorly used for alerting physicians about a possible drug allergy, as an allergic reaction to a drug can be catastrophic, even leading to death. Most of the computerized physician order entry (CPOE) databases and patients’ electronic medical records (EMRs) contain details of possible drug allergies, for the doctor to consult before prescribing medication. 

Therefore, considering how big a role CDSS and other digital health technologies can play in saving lives and improving the overall patient outcomes, they have been getting immense support from governments. For instance, the European Union (EU) invested $18.1 million in 2015 to develop the eIdentification (eID), eProcurement, eHealth, and online dispute resolution (ODR) infrastructure in the region. Similarly, under the Health Information Technology for Economic and Clinical Health (HITECH) Act, the U.S. government encourages doctors to use HIT platforms, such as EMRs, by offering them incentives.

As the usage of such systems requires a robust HIT infrastructure, North America is and will be the largest clinical decision support system market in the coming years. Moreover, the increasing healthcare spending and the reimbursement available under the Medicaid and Medicare programs make such expensive technologies affordable. In addition, the increasing geriatric population, which is expected to reach 84.8 million in the U.S. by 2050, as per the United Nations (UN), is leading to the rising patient footfall at hospitals and a greater need for remote patient monitoring and medication management solutions. 

Hence, as the healthcare niche advances and reels under increasing pressure, the requirement for CDSS and other digital technologies that can take some burden off doctors’ shoulders will keep growing.

Read More

Increasing Incidence of HIV/AIDS Driving Demand for HIV Diagnosis

The rising incidence of HIV/AIDS is one of the major factors responsible for the mushrooming demand for HIV diagnosis solutions. As per the data released by the Joint United Nations Programme on HIV/AIDS (UNAIDS), the incidence of AIDS surged by 2.8 million from 2011 to 2015 and reached around 36.7 million HIV positive people around the world in 2015. The increasing occurrence rate of this diseases means that more people are taking the HIV/AIDS diagnostic tests, which is fueling the expansion of the global HIV diagnosis market. 

Access Detailed Report - HIV Diagnosis Market Revenue Estimation Report

Furthermore, the growing public awareness about blood transfusions and blood donations, on account of the increasing implementation of various supportive initiatives by several government associations and organizations, is also propelling the requirement for HIV diagnostic tests. The World Health Organization (WHO), the American Association of Blood Banks (AABB), American Red Cross, and the International Federation of Red Cross and Red Crescent Societies (IFRC) are some of the major organizations that have actively supported various blood donor programs and encouraged the donation of blood and blood components.

Moreover, these organizations have launched initiatives for raising public awareness about blood donations, thereby resulting in a sharp rise in blood collections via voluntary donation. As per the WHO, there were around 92 million blood donations in 2011 and the number increased to 108 million in 2014. During blood transfusion, the compromised utilization of sterilized needles augments the risk of HIV. Moreover, the development of point-of-care kits and instruments for the diagnosis of HIV infections has caused a massive rise in the diagnosis rate of people suffering from HIV because of their various advantages over the conventional laboratory testing method. 

Hence, it can be said with surety that the demand for HIV diagnostic tests will surge in the coming years, mainly because of the growing prevalence of HIV, soaring healthcare expenditure, increasing number of blood donations and transfusions, and rising public awareness about HIV diagnosis procedures across the world. 

Read More

Why Are Physiotherapists in Latin America Recommending Orthopedic Garments, Soft Goods, and Braces?

Around 20.4% people in Latin America (LATAM) suffer from osteoarthritis, the Community Oriented Program for the Control of Rheumatic Diseases (COPCORD) estimates. Similarly, the incidence of road accidents and sports injuries is also rising in the region, with the increasing number of automobiles on the roads and more people opting for outdoor sports. For instance, according to the World Health Organization (WHO), per every 100,000 people, 24.8% in Ecuador and 21.5% in Colombia died in road crashes in 2018.

Browse report overview and detailed TOC at Latin America Orthopedic Garments, Soft Goods and Braces Market Demand Forecast 

P&S Intelligence says that on account of these factors, the LATAM orthopedic garments market size will increase to $376.3 million by 2030 from $223.1 million in 2019, at a 5.2% CAGR between 2020 and 2030. Similarly, the LATAM orthopedic soft goods and braces market is expected to display a 4.9% CAGR between 2020 and 2030, to grow from $177.4 million in 2019 to $291.1 million by 2030. All such products are useful in the physical rehabilitation of people with orthopedic and other musculoskeletal issues after a major injury, accident, or surgery.

As LATAM is predominantly a developing region, raising awareness about orthopedic diseases and treatment options is important. This is why many public and private organizations are hosting campaigns and seminars to educate people about muscle-and-bone-related issues and how they can be managed and treated. For instance, the International Orthopedic and Traumatology Association (IOTA) had planned to host the Mexican Federation of Associations of Traumatology and Orthopedics 31st National Congress 2020 in October, to spread awareness about the ways to manage and treat orthopedic and traumatic injuries.

Among the several types of orthopedic garments available in the region, such as socks, braces and support, sleeves, pantyhose, masks, and vests, braces and support witness the highest adoption. Such garments support the ligaments and reduce the weight the joints are subject to, in order to provide pain relief. Braces and supports are also more preferred than soft goods, as they are widely used by osteoarthritis and osteoporosis patients. Moreover, these products are utilized for patient rehabilitation and for people who have suffered a post-operative injury.

The rehabilitation of people with bone and muscle issues is generally done by physiotherapists, 350,221 of whom existed in the region in 2019, as estimated by the World Confederation for Physical Therapy. Such medical practitioners recommend orthopedic garments, soft goods, and braces, so that patients do not have to visit them that often, which helps in bringing down the healthcare spending. Therefore, with an increasing number of people suffering from musculoskeletal issues, sports injuries, and physical trauma, physiotherapists are witnessing an increasing footfall, which is driving the adoption of therapeutic and supporting goods.

Read More

Why is Demand for Automotive HMI Solutions Surging in India?

The burgeoning requirement for in-vehicle connectivity is fueling the demand for automotive human-machine-interface (HMI) solutions in India. Nowadays, people want to stay connected with the outer world, even while traveling. Moreover, automobiles are increasingly becoming more connected with the outer world via cloud services. Due to the changing customer preferences, automotive manufacturing companies are launching partnerships with consumer electronic or information technology (IT) vendors in order to integrate in-vehicle connectivity features in their offerings.

For instance, AirWire Technologies, which is a U.S. based company, received a contract from Reliance Jio Infocom Ltd., which is a telecom operator in India, for manufacturing connected car devices. Additionally, Reliance Jio Infocom Ltd. is currently in talks with leading automobile manufacturers— Hyundai Motor India and Maruti Suzuki India Ltd.— for installing connected car devices in their passenger vehicles. The incorporation of these devices in passenger vehicles will allow passengers to access services such as entertainment, telematics, location-based apps, and WiFi hotspot. 

Increasing installation of these features is driving the demand for HMIs, as these devices are required for displaying the information and enabling smoother interaction of users with in-vehicle connectivity systems. These factors are fueling the expansion of the Indian automotive HMI market. Additionally, the soaring sales of vehicles in the country, on account of the booming population and increasing urbanization rate, are also driving the growth of the Indian automotive HMI market. According to the India Brand Equity Foundation (IBEF), the sales of automobiles grew in the country at a CAGR of 1.29% from FY16 to FY20 and reached 21.55 million units in FY20.

Hence, it can be said without any hesitation that the demand for automotive HMI systems will surge in India in the coming years, mainly because of the rising requirement for in-vehicle connectivity features and the soaring sales of premium cars in the country.

Read More

What are Key Factors Causing Boom of Coronavirus Diagnostic Kit Market?

Coronavirus was initially identified in the Guangdong province of southern China in November 2002. Known by the name, severe acute respiratory syndrome coronavirus (SARS-CoV) is thought to be an animal virus that emerged from bats and became epidemic by affecting 26 countries and further resulting in more than 8,000 cases in 2003.

Browse report with detailed COVID-19 impact analysis on Coronavirus Diagnostic Kit Market Revenue Estimation and Demand Forecast

Middle East respiratory syndrome coronavirus (MERS-CoV) infection was first reported in September 2012 in Saudi Arabia. Till date, nearly 2,500 cases of this type of infection has been reported in 27 countries in a near the Arabian Peninsula. In addition, the largest outbreak of MERS-CoV outside this peninsular region occurred in the Republic of Korea in 2015.

And now, with the outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei Province, China, COVID-19, also known as SARS-CoV2 has emerged as a pandemic infection, as declared by the World Health Organization (WHO).

The 2019-novel coronavirus (2019-nCoV) real-time reverse transcription (RT) PCR diagnostic panel, provided by the Centers for Disease Control and Prevention (CDC) in the U.S., is a test intended for the qualitative detection of nucleic acid from the 2019-nCoV in upper and lower respiratory specimens such as nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) collected from individuals who meet 2019-nCoV clinical and/or epidemiological criteria. The criteria include clinical signs and symptoms associated with 2019-nCoV infection, contact with a probable or confirmed 2019-CoV case, and history of travel to geographic locations where positive cases have been detected.

Furthermore, in India, on March 24th, 2020, a Pune-based molecular diagnostic company, MylabLifesolutions Pvt. Ltd., became the first Indian company to granted validation for its COVID-19 diagnostic test kits, or RT-PCR, by the Drug Controller of India, after the validation from the National Institute of Virology. With the rapid increase in the total number of COVID-19 cases, across the globe, the need for rapid and reliable diagnostics are increasing, thereby, boosting the demand for coronavirus diagnostic kits, significantly.

Read More

Bronchoscope Market Expected to Exhibit Huge Progress during 2020–2030

 One of the major factors responsible for the rise in the demand for bronchoscopes is the rising incidence of lung cancer across the world. Since the last few years, there has been a massive rise in the global geriatric population and this has significantly boosted the prevalence of lung cancer across the globe. As per the World Health Organization (WHO), cancer was found to be the second-major cause of deaths across the globe in 2018, accounting for 9.6 million deaths, with lung cancer caused due to tobacco consumption responsible for almost 22.0% of all the lung cancer related deaths. 

Browse In-depth  Bronchoscope Market Revenue Forecast Report

There are various types of bronchoscopy technologies commonly adopted in healthcare settings — endobronchial ultrasound (EBUS), narrow-band imaging (NBI), electromagnetic navigation bronchoscopy (ENB), and autofluorescence bronchoscopy (AFB). Out of these, the EBUS technique is predicted to register the fastest growth in adoption for the diagnosis of various lung disorders and diseases. The major factor responsible for the rapidly increasing adoption of EBUS technology is the fact that this technology makes the disease diagnosis and cancer stage identification processes easier.

Bronchoscopes are extensively used in therapeutic and diagnostic applications. Between the two, these instruments are currently observing higher usage in diagnostic applications. This is mainly attributed to the fact that the bronchoscopes are widely used for the diagnosis of airway-related diseases. In addition to this, the rising awareness amongst the people about lung diseases and the importance of their early diagnosis and detection are further contributing toward the ballooning adoption of bronchoscopes in diagnostic applications.

The North American region observed the highest usage of bronchoscopes during the historical period (2014–2019), owing to the presence of a large number of lung cancer patients, huge geriatric population, advanced healthcare infrastructure, leading bronchoscope manufacturing companies, and high incidence of chronic respiratory diseases in the region. The bronchoscope market is expected to grow the fastest in Asia-Pacific (APAC) during the forecast period, owing to the rising prevalence of chronic respiratory diseases, soaring healthcare expenditure, and increasing awareness amongst the people regarding lung diseases and the importance of their early diagnosis, in the region. 

Therefore, it can be said without any hesitation that due to the mushrooming occurrence rate of lung diseases and lung cancer, improving healthcare infrastructure, and rising adoption of advanced medical instruments, the demand for bronchoscopes will increase considerably over the next few years.

Read More